Hantech Bio-Technology Co., Ltd.(TW:1294)
NT$44.80+0.25 (+0.56%)
TW:1294
Hantech Bio-Technology Co., Ltd. financials statements
NT$44.80
At close:+0.25 (+0.56%)
Hantech Bio-Technology Co., Ltd. (1294) Income Statement
Hantech Bio-Technology Co., Ltd. Income Statement
Last quarter (Q2 2026), Hantech Bio-Technology Co., Ltd.'s total revenue was NT$227.28M, an increase of 16.87% from the same quarter last year. In Q2, Hantech Bio-Technology Co., Ltd.'s net income was NT$38.11M. See Hantech Bio-Technology Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 778.54M | NT$ 748.42M | NT$ 625.14M | NT$ 302.52M | NT$ 240.29M | |
| NT$ 283.81M | NT$ 305.74M | NT$ 280.85M | NT$ 126.63M | NT$ 101.03M | |
| NT$ 110.82M | NT$ 108.30M | NT$ 95.15M | NT$ 69.19M | NT$ 62.41M | |
| Depreciation and Amortization | NT$ 38.17M | NT$ 32.07M | NT$ 20.95M | NT$ 19.32M | NT$ 18.70M |
| NT$ 211.15M | NT$ 232.09M | NT$ 206.65M | NT$ 78.52M | NT$ 58.67M | |
| NT$ 172.98M | NT$ 197.44M | NT$ 185.71M | NT$ 59.80M | NT$ 38.91M | |
| NT$ 33.00K | NT$ -2.80M | NT$ -1.14M | NT$ -2.08M | NT$ -495.00K | |
| NT$ 173.01M | NT$ 194.64M | NT$ 184.57M | NT$ 57.73M | NT$ 38.42M | |
| NT$ 139.08M | NT$ 155.67M | NT$ 148.12M | NT$ 47.47M | NT$ 32.56M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 4.60 | NT$ 6.02 | NT$ 5.34 | NT$ 1.49 | NT$ 1.02 |
| Diluted EPS | NT$ 4.60 | NT$ 5.86 | NT$ 5.34 | NT$ 1.49 | NT$ 1.02 |
| Weighted Average Shares Outstanding | 30.24M | 28.46M | 27.76M | 31.93M | 31.93M |
| Weighted Average Shares Outstanding (Diluted) | 30.24M | 29.24M | 27.76M | 31.93M | 31.93M |
Currency in TWD

